December: Anders Gersel Pedersen retires from Lundbeck

Please join us in thanking Anders Gersel Pedersen for 19 years of dedication, hard work and commitment to Lundbeck and people living with diseases of the brain.

July: Dr. Deborah Dunsire as new President and CEO

The Board of Directors of the company has appointed Dr. Deborah Dunsire as new President and CEO of Lundbeck. Dr. Dunsire will take up her new position on 1 September 2018.

June: Lundbeck's #1VoiceSummit

For the 5th year in a row, Lundbeck has the pleasure to host our global patient advocacy summit and we are happy to see advocacy groups, patient organizations and other experts from all over the world joining us at our HQ offices on 27-28 June.

June: Lundbeck starts clinical development of potential new treatment of Parkinson’s disease

Lu AF28996 is the third compound added to Lundbeck’s clinical development pipeline in 2018.

June: Lundbeck supports dementia research in Denmark

New network aims at improving the conditions for running clinical trials.

June: Lundbeck rated best in the world in regulatory affairs

A global survey of 70 pharmaceutical companies ranks Lundbeck as number one in the industry.

May: Lundbeck research enhances understanding of Alzheimer’s

Biological hypothesis behind our antibody treatment is confirmed in major step forward for the project.

April: Strong global recognition of Lundbeck’s reputation

In a worldwide survey, Lundbeck is ranked number 2 out of 46 pharma companies when it comes to our reputation among patient groups working with us.

March: Alzheimer’s researchers win world’s top brain research prize

The Brain Prize for 2018 is awarded to Bart De Strooper, Michel Goedert, Christian Haass and John Hardy for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease, with far-reaching implications for the development of new therapeutic interventions.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.